BioMarin Pharmaceutical, Inc. (NASDAQ:BMRN)

CAPS Rating: 3 out of 5

The Company develops and commercializes innovative biopharmaceuticals for serious diseases and medical conditions.

Recs

0
Player Avatar APNoah (< 20) Submitted: 9/3/2008 11:43:25 PM : Outperform Start Price: $29.21 BMRN Score: +24.81

Continuation Wedge
score = 93

Report this Post Reply

Featured Broker Partners


Advertisement